Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D. Macandog, Carlotta Catozzi, Mariaelena Capone, Amir Nabinejad, Padma P. Nanaware, Shujing Liu, Smita Vinjamuri, Johanna A. Stunnenberg, Serena Galié, Maria Giovanna Jodice, Francesca Montani, Federica Armanini, Ester Cassano, Gabriele Madonna, Domenico Mallardo, Benedetta Mazzi, Salvatore Pece, Maria Tagliamonte, Vito Vanella, Massimo Barberis, Pier Francesco Ferrucci, Christian U. Blank, Marlène Bouvier, Miles C. Andrews, Xiaowei Xu, Laura Santambrogio, Nicola Segata, Luigi Buonaguro, Emilia Cocorocchio, Paolo A. Ascierto, Teresa Manzo, Luigi Nezi
Topics & Concepts
BiologyMelanomaGut floraMicrobiologyImmunologyCancer researchGut microbiota and healthCancer Immunotherapy and BiomarkersClostridium difficile and Clostridium perfringens research